In-vitro diagnostics is a method of performing a diagnostic test to detect disease, condition or infection in an artificial environment. Molecular diagnostic is one of the major segments of in-vitro diagnostics market. Molecular diagnostics is used to measure and detect the presence of genetic material associated with specific disease. It is used to identify DNA and RNA at molecular level. Molecular diagnostics is a tool to improve clinical outcomes and medical decisions.
Molecular diagnostic includes all tests used to identify a disease, by analyzing molecules such as DNA, protein or RNA in a fluid or tissue. Nowadays molecular diagnostics is used in early detection of infectious diseases, cancer and genetic disorder, by using molecular and genetic technologies. Molecular diagnostics is also used in detection of abnormalities in pre-natal stage. In addition, molecular diagnostic kits are used in pharmacogenetics testing and blood donor screening.
Planning Forward? Access Sample of Molecular Diagnostics Market Report @ https://www.persistencemarketresearch.com/toc/2784
FACTS AT A GLANCE
Companies:Novartis AG, Roche Diagnostics, QIAGEN, Siemens Healthcare, Abbott Laboratories, Inc., Gen-Probe, Inc. (Hologic Inc.), Cepheid, Inc., Beckman Coulter, Inc., Becton, Dickinson & Company, Myriad Genetics, Inc., and bioMerieux.
Coverage: All major geographies and key segments
Segments: Molecular Diagnostics Market is Segmented by in-vitro diagnostics by using molecular and genetic technologies, Molecular Diagnostic Kitsused for Pharmacogenetics Testing and Blood Donor Screening
Geographies: North America (U.S., Canada),Latin America (Mexico, Brazil, Argentina, Chile, Peru),Western Europe (Germany, Italy, France, U.K, Spain, BENELUX, Nordic, Eastern Europe),CIS and Russia,Asia-Pacific (China, India, ASEAN, South Korea),Japan,Middle East and Africa (GCC Countries, South Africa, Turkey, Iran, Israel)
Get A Customized Scope To Match Your Need Ask An Expert – sales@persistencemarketresearch.com
ABSTRACT-
How About Re-Inventing The Methodical Wheel In The Molecular Diagnostics Market? Switch Over To The “Methodology” Tab! https://www.persistencemarketresearch.com/methodology/2784
Asia is expected to show high growth rates in the next five years in molecular diagnostics market. Some of the factors driving growth of molecular diagnostics in emerging markets are increasing demand of genetic tests, advancement in healthcare infrastructure and large patient pool in countries such as India and China.
In recent times there is increased use of molecular diagnostics due to increasing application in blood screening, genetic disorders and cancer. Increasing prevalence of chronic and infectious diseases such as HIV and hepatitis, rising awareness and acceptance of personalized medicine and companion diagnostics are also fueling growth in the global molecular diagnostics market. However, changing reimbursement regulations and delayed approval of many new molecular diagnostic tests are some of the factors inhibiting the growth for global molecular diagnostics market.
Planning To Introduce An Offbeat Product/Technology In The Molecular Diagnostics Market? Go To “Purchase Now” To Have Our Molecular Diagnostics Market Report! https://www.persistencemarketresearch.com/checkout/2784
About us: – Persistence market research
Contact Us:
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com